Suanfarma has worked with us showing customer focus, sustainability improvement efforts, expertise in the production of fermentation-origin small molecules, and reliability in supply and readiness for new busin
develop sales plans and budgets for achieving sales goals in China 2. Attract top quality sales m来自BOSS直聘embers and provide them with on‐going coaching and development to build a strong sales organization to support business growth 3. Identify and develop new business opportunities inkanzhunth...
A favorable regulatory environment, promoting and nurturing regenerative medicine development, is anticipated to enhance industry growth. Government backing, including funding and relaxed regulatory constraints, offers researchers valuable opportunities to advance stem cell therapies. Increasing investments from ...
We offer competitive salaries and benefits packages along with opportunities for professional development. Check out our vacancies and consider joining our team of experts who enjoy what they do. Careers at Cambrex If you're ready to take the next step in your career, look at our current ...
Evaluation of the market potential and opportunities for pharmaceutical CDMOs, regulatory policies, standards and inspection trends Identifying the pharma companies that are considered leaders in their field, as well as the technological means these companies are using to exploit their markets A loo...
growing prevalence of diseases, such as cancer, diabetes, and CVD, in this region is likely to increase CDMO services adoption for drug or medicine development. Stringent regulations regarding product development, manufacturing, and quality control are anticipated to create growth opportunities for domest...
The pharma industry faces countless opportunities; however, there is a problem. Business leaders are asking where has all the talent gone? This session will explore real-world insights into why the industry is facing a talent crisis. He will share those critical factors any pharmaceutical ...
13 Dec 2019 CMB International Securities | Equity Research | Sector Initiation China CRO/CDMO Sector Big opportunities in China and abroad We initiate coverage on China CRO/CDMO sector with a positive view, based on strong demand in innovative drug R&D in China and potential market share gain ...
Evaluate’s CDMO Intelligence solution combines CDMO profiles, services, manufacturing and volume forecasts with Evaluate’s biopharma expertise and financial forecast methodologies on approved and pipeline drugs. The data has been engineered to serve CDMOs and their partners, enabling them to more e...
we plan to study diverse business opportunities across various areas including AAV. Our aim is to accelerate our platform and business growth by investing in ADC facilities and forming strategic partnerships with biotech companies that have advanced and promising ADC technologies.Biosimilar Business: Prepa...